Interleukin 32, inflammation and cancer

JT Hong, DJ Son, CK Lee, DY Yoon, DH Lee… - Pharmacology & …, 2017 - Elsevier
Abstract Interleukin-32 (IL-32) is a novel cytokine involved in inflammation and cancer
development. IL-32 gene consists of eight small exons, and IL-32 mRNA has nine …

[HTML][HTML] Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3–p38 MAPK signalling

S Wen, Y Hou, L Fu, L Xi, D Yang, M Zhao, Y Qin… - Cancer letters, 2019 - Elsevier
Metastasis is the leading cause of breast cancer–related deaths. Cancer-associated
fibroblasts (CAFs), the predominant stromal cell type in the breast tumour microenvironment …

Insights into the role of IL-32 in cancer

YJE Sloot, JW Smit, LAB Joosten… - Seminars in immunology, 2018 - Elsevier
Abstract Interleukin 32 (IL-32) is a proinflammatory cytokine involved in the development of
several diseases, including cancer. IL-32 is a rather peculiar cytokine because its protein …

[HTML][HTML] NF-κB pathway in colitis-associated cancers

E Viennois, F Chen, D Merlin - Translational gastrointestinal …, 2013 - ncbi.nlm.nih.gov
Colitis-associated cancer is the subtype of colorectal cancer that is associated with
inflammatory bowel diseases including ulcerative colitis and Crohn's disease. Colorectal …

Novel insights into the biology of interleukin-32

LAB Joosten, B Heinhuis, MG Netea… - Cellular and molecular …, 2013 - Springer
Abstract Interleukin (IL)-32 is known as a proinflammatory cytokine that is likely involved in
several diseases, including infections, chronic inflammation, and cancer. Since the first …

Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2, 3-dioxygenase (IDO) expression

H Yan, M Dong, X Liu, Q Shen, D He, X Huang… - Cancer letters, 2019 - Elsevier
The interaction of multiple myeloma (MM) cells with macrophages (MΦs) contributes to the
pathophysiology of MM. We previously showed that IL-32 is overexpressed in MM patients …

Targeting TIGIT inhibits bladder cancer metastasis through suppressing IL-32

K Wu, J Zeng, X Shi, J Xie, Y Li, H Zheng… - Frontiers in …, 2022 - frontiersin.org
Bladder cancer is a highly metastatic tumor and one of the most common malignancies
originating in the urinary tract. Despite the efficacy of immune checkpoints, including …

IL-32 promotes angiogenesis

CA Nold-Petry, I Rudloff, Y Baumer, M Ruvo… - The Journal of …, 2014 - journals.aai.org
IL-32 is a multifaceted cytokine with a role in infections, autoimmune diseases, and cancer,
and it exerts diverse functions, including aggravation of inflammation and inhibition of virus …

IL-32 and its paradoxical role in neoplasia

JT Hough, L Zhao, M Lequio, AJ Heslin, H Xiao… - Critical Reviews in …, 2023 - Elsevier
Abstract Interleukin-32 (IL-32) is an interleukin cytokine usually linked to inflammation. In
recent years, it has been found that IL-32 exhibits both pro-and anti-tumor effects. Although …

Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines

B Heinhuis, TS Plantinga, G Semango… - …, 2016 - academic.oup.com
Alternative splicing is a biological mechanism that enables the synthesis of several isoforms
with different or even opposite functions. This process must be tightly regulated to prevent …